AMPH 8-K 2026-01-12

Amphastar Pharmaceuticals, Inc. (AMPH) 8-K dated 2026-01-12 — accession 0001297184-26-000002. This URL is the filing, not the AMPH hub.

Amphastar Pharmaceuticals, Inc. (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.

Amphastar Pharmaceuticals, Inc. filed a 8-K on 2026-01-12. Accession 0001297184-26-000002.

Cached items: 1.01, 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AMPH revenue for 2026-06-30 was $355.1M. Net income was $36.8M. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.

Not investment advice. The AMPH SEC hub lists recent forms. The stock page is the research view.